Organism name | Catharanthus roseus |
---|---|
Genus | Catharanthus |
Family | Apocynaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Catharanthus roseus |
---|---|
Linked NCBI taxonomy ID | 4058 |
Linked level | species |
Family in NCBI taxonomy | Apocynaceae |
---|---|
ID | 4056 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
Species | Activity |
---|---|
Catharanthus roseus (L.) G. Don | Analgesic |
Catharanthus roseus (L.) G. Don | Antibacterial |
Catharanthus roseus (L.) G. Don | Anticancer |
Catharanthus roseus (L.) G. Don | Antidiabetic |
Catharanthus roseus (L.) G. Don | Antileukemic |
Catharanthus roseus (L.) G. Don | Antimitotic |
Catharanthus roseus (L.) G. Don | Antipyretic |
Catharanthus roseus (L.) G. Don | Antiseptic |
Catharanthus roseus (L.) G. Don | CNS Depressant |
Catharanthus roseus (L.) G. Don | Collyrium |
Catharanthus roseus (L.) G. Don | Depurative |
Catharanthus roseus (L.) G. Don | Digitalic |
Catharanthus roseus (L.) G. Don | Diuretic |
Catharanthus roseus (L.) G. Don | Emetic |
Catharanthus roseus (L.) G. Don | Fungicide |
Catharanthus roseus (L.) G. Don | Hemostat |
Catharanthus roseus (L.) G. Don | Hypoglycemic |
Catharanthus roseus (L.) G. Don | Hypotensive |
Catharanthus roseus (L.) G. Don | Laxative |
Catharanthus roseus (L.) G. Don | Leukopenic |
Catharanthus roseus (L.) G. Don | Myorelaxant |
Catharanthus roseus (L.) G. Don | Sedative |
Catharanthus roseus (L.) G. Don | Teratogenic |
Catharanthus roseus (L.) G. Don | Tranquilizer |
Catharanthus roseus (L.) G. Don | Vermifuge |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00013985
![]() |
Syringetin 3-robinobioside
/ Myricetin 3',5'-dimethyl ether 3-robinobioside / 3-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-galactopyranosyl]oxy]-5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-4H-1-benzopyran-4-one |
No. 1 | No. 15 |
![]() |
||||
C00006722
![]() |
Petunidin 3-glucoside
/ Petunidin 3-O-beta-D-glucopyranoside |
CHEMBL1784264
|
C455107
|
No. 2 | No. 15 |
![]() |
||
C00006735
![]() |
Oenin
/ Malvidin 3-O-beta-D-glucopyranoside |
CHEMBL403236
|
C458419
|
1 / 0 | No. 2 | No. 15 |
![]() |
|
C00014876
![]() |
Hirsutidin 3-glucoside
|
No. 2 | No. 15 |
![]() |
||||
C00005206
![]() |
Mauritianin
/ 3-O-[2,6-di-O-alpha-L-rhamnopyranosyl-beta-D-galactopyranosyl] kaempferol |
CHEMBL362593
CHEMBL1454324 CHEMBL2005346 |
C069907
|
1 / 0 / 0 | No. 5 | No. 15 |
![]() |
|
C00014875
![]() |
Hirsutidin 3-O-(6-O-p-coumaroyl)glucoside
|
No. 30 | No. 15 |
![]() |
||||
C00006896
![]() |
Petunidin 3-(6''-p-coumarylglucoside)
|
No. 30 | No. 15 |
![]() |
||||
C00006903
![]() |
Malvidin 3-(6''-p-coumarylglucoside)
|
No. 30 | No. 15 |
![]() |
||||
C00003088
![]() |
Loganin
|
CHEMBL1081584
CHEMBL1081586 CHEMBL1589904 CHEMBL2135791 |
C059516
|
2 / 1 / 1 | 0 / 1 | No. 56 | No. 36 |
![]() |
C00024458
![]() |
Hazuntine
/ (-)-Hazuntine / (-)-Lochnerinine |
No. 61 | No. 4 |
![]() |
||||
C00024480
![]() |
11-Hydroxytabersonine
|
CHEMBL2011510
|
No. 61 | No. 4 |
![]() |
|||
C00024501
![]() |
19R-Hydroxytabersonine
|
No. 61 | No. 4 |
![]() |
||||
C00024481
![]() |
11-Methoxytabersonine
/ 16-Methoxytabersonine / (-)-11-Methoxytabersonine |
CHEMBL1165751
|
No. 61 | No. 4 |
![]() |
|||
C00024457
![]() |
Lochnericine
/ (-)-Lochnericine |
CHEMBL2011514
|
No. 61 | No. 4 |
![]() |
|||
C00024499
![]() |
Vandrikidine
/ 19R-Hydroxy-11-methoxy-tabersonine |
CHEMBL2011513
|
No. 61 | No. 4 |
![]() |
|||
C00024459
![]() |
(-)-Minovincinine
|
No. 61 | No. 4 |
![]() |
||||
C00010604
![]() |
Loganic acid
|
CHEMBL1081585
CHEMBL1079678 CHEMBL1356464 CHEMBL1452775 |
C002947
|
6 / 8 / 7 | No. 64 | No. 36 |
![]() |
|
C00000181
![]() |
Castasterone
|
C083545
|
No. 68 | No. 11 |
![]() |
|||
C00007276
![]() |
5-alpha-Campestanol
|
No. 68 | No. 11 |
![]() |
||||
C00000176
![]() |
Brassinolide
|
CHEMBL563853
CHEMBL1801925 CHEMBL1967970 |
C023623
|
16 / 2 | No. 68 | No. 11 |
![]() |
|
C00007273
![]() |
6-Oxocampestanol
|
No. 68 | No. 11 |
![]() |
||||
C00000024
![]() |
GA24
/ Gibberellin A24 |
C120176
|
No. 187 | No. 41 |
![]() |
|||
C00000012
![]() |
GA12
/ Gibberellin A12 |
C048462
|
No. 187 | No. 41 |
![]() |
|||
C00024498
![]() |
19S-Vindolinine
/ 19-Epivindolinine / 20-Epivindolinine / 20-epi-Vindolinine |
CHEMBL1165590
CHEMBL1330793 |
15 / 8 / 12 | No. 527 |
![]() |
|||
C00024462
![]() |
(-)-Venalstonine
|
No. 527 |
![]() |
|||||
C00003098
![]() |
Secologanin
|
CHEMBL1235867
CHEMBL1971881 |
C021086
|
1 / 0 / 0 | No. 806 | No. 36 |
![]() |
|
C00000206
![]() |
Saligel
/ Salonil / Salicylic acid / 2-Carboxyphenol / o-Hydroxybenzoic acid |
CHEMBL424
|
D020156
|
124 / 50 / 42 | 15 / 12 | No. 817 | No. 81 |
![]() |
C00024523
![]() |
Cathovaline
/ Cathanneine |
No. 1218 | No. 4 |
![]() |
||||
C00024529
![]() |
NSC 91993
/ Deacetylvindoline / Desacetylvindoline |
No. 1218 | No. 4 |
![]() |
||||
C00024521
![]() |
Bannucine
|
No. 1218 | No. 4 |
![]() |
||||
C00024613
![]() |
Vindoline
/ Vindolin / NSC 91994 / (-)-Vindoline |
CHEMBL526546
CHEMBL1317962 CHEMBL2001832 |
C009667
|
3 / 1 / 1 | No. 1218 | No. 4 |
![]() |
|
C00024616
![]() |
NSC 94038
/ Vindorosine / Vindorosin / Vindolidin / Vindolidine / (+)-Vindorosine / Demethoxyvindoline |
No. 1218 | No. 4 |
![]() |
||||
C00001122
![]() |
Glucose
/ D-Glucose / alpha-D-Glucose |
CHEMBL300520
CHEMBL98182 CHEMBL103010 CHEMBL423707 CHEMBL195923 CHEMBL469448 CHEMBL1222152 CHEMBL1222250 CHEMBL1233058 CHEMBL1453070 CHEMBL1519430 CHEMBL1614854 CHEMBL1873035 CHEMBL2093058 CHEMBL2115552 |
26 / 15 / 15 | No. 1283 |
![]() |
|||
C00001680
![]() |
(-)-Akuammicine:Akuammicine
|
CHEMBL508955
|
No. 1800 | No. 4 |
![]() |
|||
C00000207
![]() |
Benzoic acid
|
CHEMBL541
|
D019817
|
97 / 39 / 33 | 24 / 1 | No. 2192 |
![]() |
|
C00001783
![]() |
Vincristine
|
CHEMBL90555
CHEMBL1363013 CHEMBL1396825 CHEMBL1740907 CHEMBL2134016 |
D014750
|
129 / 70 / 70 | 230 / 265 | No. 2360 | No. 4 |
![]() |
C00024497
![]() |
/ 19-Epivindolinine N-oxide / 20-Epivindolinine N-oxide / 20-Epivindolinine Nb-oxide |
No. 2586 |
![]() |
|||||
C00024615
![]() |
Vindolinine
/ 19R-vindolinine / (-)-Vindolinine |
C009668
|
No. 2586 |
![]() |
||||
C00024614
![]() |
Vindolinine N-oxide
/ Vindolinine Nb-oxide |
No. 2586 |
![]() |
|||||
C00000091
![]() |
trans-Zeatin
|
CHEMBL525239
|
D015026
|
2 / 3 / 2 | 0 / 1 | No. 2879 |
![]() |
|
C00001386
![]() |
L-Phenylalanine
|
CHEMBL25080
CHEMBL301523 CHEMBL379630 |
27 / 18 / 14 | No. 3303 |
![]() |
|||
C00000733
![]() |
Chorismic acid
|
CHEMBL1160745
|
D002827
|
No. 3811 |
![]() |
|||
C00000734
![]() |
Isochorismic acid
|
C052985
|
No. 3811 |
![]() |
||||
C00024486
![]() |
14,15-Dehydroepivincadine
/ (+)-6,7-Dehydroepivincadine / 14,15-Didehydro-epivincadine / 6,7-Didehydro-3-epivincadine |
No. 5393 |
![]() |
|||||
C00007560
![]() |
Dihydroxyacetone phosphate
|
CHEMBL1161998
|
D004099
|
No. 7554 |
![]() |
|||
C00007614
![]() |
Isochorismate
|
No. 8480 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000206 C00000207 C00001386 C00001783 C00024613 | 0 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000206 C00000207 C00001386 C00001783 | 1 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000206 C00000207 C00001386 C00001783 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00000206 C00000207 C00001386 C00001783 | 1 / 1 |
O75496 | Geminin | Unclassified protein | C00000206 C00001783 C00003088 C00024498 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000206 C00000207 C00001386 C00001783 | 0 / 1 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000206 C00000207 C00001386 C00001783 | 1 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000206 C00000207 C00001386 C00001783 | 0 / 1 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001386 C00001783 C00010604 C00024498 | 0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000206 C00000207 C00001386 C00001783 | 1 / 2 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000206 C00000207 C00001783 | 1 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00000206 C00000207 C00001783 | 0 / 1 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000206 C00000207 C00001783 | 0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000206 C00000207 C00001783 | 2 / 2 |
P08246 | Neutrophil elastase | S1A | C00000206 C00000207 C00001783 | 2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000206 C00000207 C00001783 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000206 C00000207 C00001783 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000206 C00000207 C00001783 | 5 / 9 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000206 C00000207 C00001783 | 2 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000206 C00000207 C00001783 | 1 / 1 |
P17252 | Protein kinase C alpha type | Alpha | C00000206 C00000207 C00001783 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00000206 C00000207 C00001783 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000206 C00000207 C00001783 | 2 / 2 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000206 C00000207 C00001783 | 1 / 1 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000206 C00000207 C00001783 | 2 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00000206 C00000207 C00001783 | 0 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000206 C00000207 C00001783 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000206 C00000207 C00001783 | 1 / 1 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00000206 C00000207 C00001783 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000206 C00000207 C00001783 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00000206 C00000207 C00001783 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00000206 C00001783 C00024613 | 1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00000206 C00000207 C00001783 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000206 C00000207 C00001783 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000206 C00000207 C00001783 | 3 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000206 C00000207 C00001783 | 0 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000206 C00000207 C00001783 | 0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00001122 C00010604 C00024498 | 1 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000206 C00000207 C00001783 | 1 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000206 C00000207 C00001783 | 1 / 8 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00000206 C00000207 C00001783 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000206 C00000207 C00001783 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000206 C00000207 C00001783 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000206 C00000207 C00001783 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000206 C00000207 C00001783 | 1 / 1 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000206 C00000207 C00001783 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000206 C00000207 C00001783 | 1 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000206 C00000207 C00001783 | 2 / 1 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000206 C00000207 C00001783 | 0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00000206 C00000207 C00001783 | 1 / 0 |
P03956 | Interstitial collagenase | M10A | C00000206 C00000207 C00001783 | 0 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000206 C00000207 C00001783 | 1 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00001783 C00010604 C00024498 | 2 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000206 C00000207 C00001783 | 1 / 0 |
P08311 | Cathepsin G | S1A | C00000206 C00000207 C00001783 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000206 C00000207 C00001783 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000206 C00000207 C00001783 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00000206 C00000207 C00001783 | 1 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000206 C00000207 C00001783 | 1 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000206 C00000207 C00001783 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P25021 | Histamine H2 receptor | Histamine receptor | C00000206 C00000207 C00001783 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00000206 C00001122 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00001783 C00024498 | 1 / 1 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001783 C00024498 | 0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00000206 C00001386 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00000206 C00000207 | 0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001122 C00024498 | 1 / 2 |
O00255 | Menin | Unclassified protein | C00001122 C00024498 | 2 / 5 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00000206 C00001386 | 0 / 1 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00000206 C00001122 | 0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | C00000206 C00001386 | 1 / 2 |
P01215 | Glycoprotein hormones alpha chain | Unclassified protein | C00010604 C00024498 | 0 / 3 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00000206 C00001386 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00000206 C00001386 | 0 / 0 |
P60033 | CD81 antigen | Unclassified protein | C00003088 C00010604 | 1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001783 C00024498 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001122 C00001783 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000206 C00024613 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001122 C00001386 | 0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00000206 C00001386 | 1 / 1 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00001122 C00001386 | 3 / 1 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000091 C00000207 | 3 / 2 |
P07451 | Carbonic anhydrase 3 | Lyase | C00000206 C00001386 | 0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00000206 C00001386 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00000206 C00001386 | 0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00000206 C00001386 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001386 C00001783 | 2 / 0 |
P11217 | Glycogen phosphorylase, muscle form | Enzyme | C00001122 | 1 / 1 |
Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00001783 | 1 / 0 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00024498 | 0 / 0 |
Q4U2R8 | Solute carrier family 22 member 6 | Antiporter | C00000206 | 0 / 0 |
P11308 | Transcriptional regulator ERG | Unclassified protein | C00001122 | 1 / 2 |
P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00001386 | 3 / 1 |
P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00001386 | 0 / 0 |
Q9GZT4 | Serine racemase | Enzyme | C00000207 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00024498 | 0 / 0 |
P08253 | 72 kDa type IV collagenase | M10A | C00000206 | 1 / 3 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00001783 | 1 / 1 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000206 | 2 / 2 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | C00024498 | 1 / 1 |
P07306 | Asialoglycoprotein receptor 1 | Membrane receptor | C00001122 | 0 / 0 |
P06133 | UDP-glucuronosyltransferase 2B4 | Enzyme | C00000206 | 0 / 0 |
P36537 | UDP-glucuronosyltransferase 2B10 | Enzyme | C00000206 | 0 / 0 |
Q8TCC7 | Solute carrier family 22 member 8 | Antiporter | C00000206 | 0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | C00024498 | 0 / 0 |
P42858 | Huntingtin | Unclassified protein | C00001783 | 1 / 1 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00001783 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000206 | 0 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00001783 | 0 / 0 |
O14920 | Inhibitor of nuclear factor kappa-B kinase subunit beta | Other serine/threonine protein kinase | C00000206 | 0 / 0 |
P05067 | Amyloid beta A4 protein | Membrane receptor | C00000206 | 2 / 2 |
P11216 | Glycogen phosphorylase, brain form | Enzyme | C00001122 | 0 / 0 |
P11926 | Ornithine decarboxylase | Lyase | C00001783 | 0 / 0 |
P11387 | DNA topoisomerase 1 | Isomerase | C00005206 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00001783 | 0 / 0 |
P14920 | D-amino-acid oxidase | Enzyme | C00000207 | 0 / 0 |
P09382 | Galectin-1 | Other cytosolic protein | C00001122 | 0 / 0 |
P08236 | Beta-glucuronidase | Enzyme | C00000206 | 1 / 2 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00024498 | 0 / 0 |
Q9UQ49 | Sialidase-3 | Enzyme | C00000207 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00010604 | 4 / 3 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00000207 | 0 / 0 |
P02768 | Serum albumin | Secreted protein | C00000206 | 0 / 0 |
Q9Y263 | Phospholipase A-2-activating protein | Unclassified protein | C00001386 | 0 / 0 |
P11226 | Mannose-binding protein C | Unclassified protein | C00001122 | 2 / 2 |
P02545 | Prelamin-A/C | Unclassified protein | C00001783 | 11 / 10 |
Q99489 | D-aspartate oxidase | Enzyme | C00000207 | 0 / 0 |
P14679 | Tyrosinase | Oxidoreductase | C00001386 | 4 / 2 |
P22894 | Neutrophil collagenase | M10A | C00000206 | 0 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00000206 | 0 / 0 |
Q9NNX6 | CD209 antigen | Unclassified protein | C00001122 | 2 / 0 |
P08254 | Stromelysin-1 | M10A | C00000206 | 1 / 0 |
P07900 | Heat shock protein HSP 90-alpha | Other cytosolic protein | C00003098 | 0 / 0 |
Q6P4F1 | Alpha-(1,3)-fucosyltransferase 10 | Enzyme | C00001122 | 0 / 0 |
Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00001783 | 1 / 0 |
P17931 | Galectin-3 | Other cytosolic protein | C00001122 | 0 / 1 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00001122 | 0 / 0 |
Q9UHC3 | Acid-sensing ion channel 3 | Unclassified protein | C00000206 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00000206 | 4 / 1 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00000091 | 0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | C00001783 | 1 / 1 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00001783 | 7 / 37 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00001122 | 1 / 1 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00000206 | 0 / 0 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00001783 | 0 / 0 |
P10323 | Acrosin | S1A | C00001122 | 0 / 0 |
Q96QA9 | Multidrug resistance associated protein | Unclassified protein | C00001783 | 0 / 0 |
Q9NSA0 | Solute carrier family 22 member 11 | Transporter | C00000206 | 0 / 0 |
Q5T3U5 | Multidrug resistance-associated protein 7 | Unclassified protein | C00001783 | 0 / 0 |
Q05BR4 | SLC16A10 protein | Unclassified protein | C00001386 | 0 / 0 |
Q13748 | Tubulin alpha-3C/D chain | Structural | C00001783 | 0 / 0 |
P68366 | Tubulin alpha-4A chain | Structural | C00001783 | 0 / 0 |
Q9H4B7 | Tubulin beta-1 chain | Structural | C00001783 | 1 / 0 |
P04350 | Tubulin beta-4A chain | Structural | C00001783 | 2 / 0 |
Q3ZCM7 | Tubulin beta-8 chain | Structural | C00001783 | 0 / 0 |
P07437 | Tubulin beta chain | Structural | C00001783 | 0 / 0 |
Q71U36 | Tubulin alpha-1A chain | Structural | C00001783 | 1 / 1 |
P68371 | Tubulin beta-4B chain | Structural | C00001783 | 0 / 0 |
Q13509 | Tubulin beta-3 chain | Structural | C00001783 | 2 / 1 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00001783 | 0 / 0 |
Q9UJ71 | C-type lectin domain family 4 member K | Unclassified protein | C00001122 | 1 / 0 |
P22897 | Macrophage mannose receptor 1 | Unclassified protein | C00001122 | 0 / 0 |
Q8WTT0 | C-type lectin domain family 4 member C | Unclassified protein | C00001122 | 0 / 0 |
Q6EIG7 | C-type lectin domain family 6 member A | Unclassified protein | C00001122 | 0 / 0 |
P35247 | Pulmonary surfactant-associated protein D | Unclassified protein | C00001122 | 0 / 0 |
Q9H2X3 | C-type lectin domain family 4 member M | Unclassified protein | C00001122 | 0 / 0 |
P68363 | Tubulin alpha-1B chain | Unclassified protein | C00001783 | 0 / 0 |
Q13885 | Tubulin beta-2A chain | Structural | C00001783 | 0 / 0 |
Q6PEY2 | Tubulin alpha-3E chain | Unclassified protein | C00001783 | 0 / 0 |
Q9BQE3 | Tubulin alpha-1C chain | Unclassified protein | C00001783 | 0 / 0 |
Q9BUF5 | Tubulin beta-6 chain | Structural | C00001783 | 0 / 0 |
Q9BVA1 | Tubulin beta-2B chain | Structural | C00001783 | 1 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000176
C00001783
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00000176
C00001783
|
7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00000206
C00000207
|
4489 | MT1A, MT1, MT1S, MTC | metallothionein 1A |
C00000206
C00000207
|
891 | CCNB1, CCNB | cyclin B1 |
C00000176
C00001783
|
8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00000206
C00000207
|
1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) |
C00000206
C00000207
|
2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00000207
C00001783
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00000207
C00001783
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000176
C00001783
|
4193 | MDM2, ACTFS, HDMX, hdm2 | MDM2 oncogene, E3 ubiquitin protein ligase |
C00000176
C00001783
|
51646 | YPEL5 | yippee-like 5 (Drosophila) |
C00001783
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000176
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00000176
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00000176
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00000176
|
8654 | PDE5A, CGB-PDE, CN5A, PDE5 | phosphodiesterase 5A, cGMP-specific (EC:3.1.4.35) |
C00006735
|
19 | ABCA1, ABC-1, ABC1, CERP, HDLDT1, TGD | ATP-binding cassette, sub-family A (ABC1), member 1 |
C00001783
|
26154 | ABCA12, ARCI4A, ARCI4B, ICR2B, LI2 | ATP-binding cassette, sub-family A (ABC1), member 12 |
C00001783
|
24 | ABCA4, ABC10, ABCR, ARMD2, CORD3, FFM, RMP, RP19, STGD, STGD1 | ATP-binding cassette, sub-family A (ABC1), member 4 |
C00001783
|
23461 | ABCA5, ABC13, EST90625 | ATP-binding cassette, sub-family A (ABC1), member 5 |
C00001783
|
10351 | ABCA8 | ATP-binding cassette, sub-family A (ABC1), member 8 |
C00001783
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00001783
|
8647 | ABCB11, ABC16, BRIC2, BSEP, PFIC-2, PFIC2, PGY4, SPGP | ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
C00001783
|
5244 | ABCB4, ABC21, GBD1, ICP3, MDR2, MDR2/3, MDR3, PFIC-3, PGY3 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 (EC:3.6.3.44) |
C00001783
|
10058 | ABCB6, ABC, ABC14, DUH3, LAN, MCOPCB7, MTABC3, PRP, umat | ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
C00001783
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00001783
|
89845 | ABCC10, EST182763, MRP7, SIMRP7 | ATP-binding cassette, sub-family C (CFTR/MRP), member 10 |
C00001783
|
1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
C00001783
|
8714 | ABCC3, ABC31, EST90757, MLP2, MOAT-D, MRP3, cMOAT2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
C00001783
|
10257 | ABCC4, EST170205, MOAT-B, MOATB, MRP4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
C00001783
|
10057 | ABCC5, ABC33, EST277145, MOAT-C, MOATC, MRP5, SMRP, pABC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
C00001783
|
368 | ABCC6, ABC34, ARA, EST349056, GACI2, MLP1, MOAT-E, MOATE, MRP6, PXE, PXE1, URG7 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
C00001783
|
5825 | ABCD3, ABC43, PMP70, PXMP1, ZWS2 | ATP-binding cassette, sub-family D (ALD), member 3 |
C00001783
|
9619 | ABCG1, ABC8, WHITE1 | ATP-binding cassette, sub-family G (WHITE), member 1 |
C00001783
|
9429 | ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR1, UAQTL1 | ATP-binding cassette, sub-family G (WHITE), member 2 |
C00001783
|
64137 | ABCG4, WHITE2 | ATP-binding cassette, sub-family G (WHITE), member 4 |
C00001783
|
81569 | ACTL8, CT57 | actin-like 8 |
C00001783
|
154 | ADRB2, ADRB2R, ADRBR, B2AR, BAR, BETA2AR | adrenoceptor beta 2, surface |
C00001783
|
57379 | AICDA, AID, ARP2, CDA2, HIGM2 | activation-induced cytidine deaminase (EC:3.5.4.38) |
C00001783
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00001783
|
216 | ALDH1A1, ALDC, ALDH-E1, ALDH1, ALDH11, PUMB1, RALDH1 | aldehyde dehydrogenase 1 family, member A1 (EC:1.2.1.36) |
C00001783
|
410 | ARSA, MLD | arylsulfatase A (EC:3.1.6.8) |
C00001783
|
259266 | ASPM, ASP, Calmbp1, MCPH5 | asp (abnormal spindle) homolog, microcephaly associated (Drosophila) |
C00001783
|
538 | ATP7A, DSMAX, MK, MNK, SMAX3 | ATPase, Cu++ transporting, alpha polypeptide (EC:3.6.3.54) |
C00001783
|
540 | ATP7B, PWD, WC1, WD, WND | ATPase, Cu++ transporting, beta polypeptide (EC:3.6.3.54) |
C00001783
|
6790 | AURKA, AIK, ARK1, AURA, AURORA2, BTAK, PPP1R47, STK15, STK6, STK7 | aurora kinase A (EC:2.7.11.1) |
C00001783
|
551 | AVP, ADH, ARVP, AVP-NPII, AVRP, VP | arginine vasopressin |
C00001783
|
578 | BAK1, BAK, BAK-LIKE, BCL2L7, CDN1 | BCL2-antagonist/killer 1 |
C00001783
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00001783
|
672 | BRCA1, BRCAI, BRCC1, BROVCA1, IRIS, PNCA4, PPP1R53, PSCP, RNF53 | breast cancer 1, early onset |
C00001783
|
675 | BRCA2, BRCC2, BROVCA2, FACD, FAD, FAD1, FANCB, FANCD, FANCD1, GLM3, PNCA2 | breast cancer 2, early onset |
C00001783
|
100170841 | C17orf96 | chromosome 17 open reading frame 96 |
C00001783
|
8618 | CADPS, CADPS1, CAPS, CAPS1 | Ca++-dependent secretion activator |
C00001783
|
84254 | CAMKK1, CAMKKA | calcium/calmodulin-dependent protein kinase kinase 1, alpha (EC:2.7.11.17) |
C00001783
|
57082 | CASC5, AF15Q14, CT29, D40, KNL1, PPP1R55, Spc7, hKNL-1, hSpc105 | cancer susceptibility candidate 5 |
C00001783
|
839 | CASP6, MCH2 | caspase 6, apoptosis-related cysteine peptidase (EC:3.4.22.59) |
C00001783
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00001783
|
847 | CAT | catalase (EC:1.11.1.6) |
C00001783
|
890 | CCNA2, CCN1, CCNA | cyclin A2 |
C00001783
|
960 | CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MIC4, Pgp1 | CD44 molecule (Indian blood group) |
C00001783
|
157313 | CDCA2, Repo-Man | cell division cycle associated 2 |
C00001783
|
1020 | CDK5, PSSALRE | cyclin-dependent kinase 5 (EC:2.7.11.22) |
C00001783
|
1022 | CDK7, CAK1, CDKN7, HCAK, MO15, STK1, p39MO15 | cyclin-dependent kinase 7 (EC:2.7.11.23 2.7.11.22) |
C00001783
|
1029 | CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16 | cyclin-dependent kinase inhibitor 2A |
C00001783
|
1051 | CEBPB, C/EBP-beta, CRP2, IL6DBP, LAP, LIP, NF-IL6, TCF5 | CCAAT/enhancer binding protein (C/EBP), beta |
C00001783
|
11190 | CEP250, C-NAP1, CEP2, CNAP1 | centrosomal protein 250kDa |
C00001783
|
23563 | CHST5, I-GlcNAc-6-ST, I-GlcNAc6ST, glcNAc6ST-3, gn6st-3, hIGn6ST | carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5 |
C00001783
|
57019 | CIAPIN1, 2810413N20Rik, Anamorsin, DRE2, PRO0915 | cytokine induced apoptosis inhibitor 1 |
C00001783
|
23242 | COBL | cordon-bleu WH2 repeat protein |
C00001783
|
1299 | COL9A3, DJ885L7.4.1, EDM3, IDD, MED | collagen, type IX, alpha 3 |
C00001783
|
1396 | CRIP1, CRHP, CRIP, CRP-1, CRP1 | cysteine-rich protein 1 (intestinal) |
C00001783
|
1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa |
C00001783
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00001783
|
1558 | CYP2C8, CPC8, CYPIIC8, MP-12/MP-20 | cytochrome P450, family 2, subfamily C, polypeptide 8 (EC:1.14.14.1) |
C00001783
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00001783
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00001783
|
1577 | CYP3A5, CP35, CYPIIIA5, P450PCN3, PCN3 | cytochrome P450, family 3, subfamily A, polypeptide 5 (EC:1.14.14.1) |
C00001783
|
1582 | CYP8B1, CP8B, CYP12 | cytochrome P450, family 8, subfamily B, polypeptide 1 (EC:1.14.13.95) |
C00001783
|
1617 | DAZ1, DAZ, SPGY | deleted in azoospermia 1 |
C00001783
|
57054 | DAZ3, pDP1679 | deleted in azoospermia 3 |
C00001783
|
57135 | DAZ4, pDP1680, pDP1681 | deleted in azoospermia 4 |
C00001783
|
11056 | DDX52, HUSSY19, ROK1 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 52 (EC:3.6.4.13) |
C00001783
|
9046 | DOK2, p56DOK, p56dok-2 | docking protein 2, 56kDa |
C00001783
|
1806 | DPYD, DHP, DHPDHASE, DPD | dihydropyrimidine dehydrogenase (EC:1.3.1.2) |
C00001783
|
1958 | EGR1, AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225 | early growth response 1 |
C00001783
|
79071 | ELOVL6, FACE, FAE, LCE | ELOVL fatty acid elongase 6 (EC:2.3.1.199) |
C00001783
|
2052 | EPHX1, EPHX, EPOX, HYL1, MEH | epoxide hydrolase 1, microsomal (xenobiotic) (EC:3.3.2.9) |
C00001783
|
2064 | ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1 | v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1) |
C00001783
|
2068 | ERCC2, COFS2, EM9, TTD, XPD | excision repair cross-complementing rodent repair deficiency, complementation group 2 (EC:3.6.4.12) |
C00001783
|
9156 | EXO1, HEX1, hExoI | exonuclease 1 |
C00001783
|
2147 | F2, PT, RPRGL2, THPH1 | coagulation factor II (thrombin) (EC:3.4.21.5) |
C00001783
|
2152 | F3, CD142, TF, TFA | coagulation factor III (thromboplastin, tissue factor) |
C00001783
|
84668 | FAM126A, DRCTNNB1A, HCC, HLD5, HYCC1 | family with sequence similarity 126, member A |
C00001783
|
55215 | FANCI, KIAA1794 | Fanconi anemia, complementation group I |
C00001783
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00001783
|
9103 | FCGR2C, CD32, CD32C, CDW32, FCG2, FCRIIC, IGFR2 | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) |
C00001783
|
2264 | FGFR4, CD334, JTK2, TKF | fibroblast growth factor receptor 4 (EC:2.7.10.1) |
C00001783
|
9896 | FIG4, ALS11, CMT4J, KIAA0274, SAC3, YVS, dJ249I4.1 | FIG4 homolog, SAC1 lipid phosphatase domain containing (S. cerevisiae) |
C00001783
|
2528 | FUT6, FCT3A, FT1A, Fuc-TVI, FucT-VI | fucosyltransferase 6 (alpha (1,3) fucosyltransferase) (EC:2.4.1.65) |
C00001783
|
26748 | GAGE12I, AL4, CT4.7, GAGE-7B, GAGE7B | G antigen 12I |
C00001783
|
2574 | GAGE2C, CT4.2, GAGE-2, GAGE-2C, GAGE2 | G antigen 2C |
C00001783
|
2575 |
C00001783
|
||
2576 | GAGE4, CT4.4 | G antigen 4 |
C00001783
|
2578 | GAGE6, CT4.6 | G antigen 6 |
C00001783
|
2579 | GAGE7, AL4, CT4.7, GAGE-7 | G antigen 7 |
C00001783
|
1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00000176
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00000176
|
51608 | GET4, C7orf20, CEE, TRC35 | golgi to ER traffic protein 4 homolog (S. cerevisiae) |
C00001783
|
2690 | GHR, GHBP | growth hormone receptor |
C00001783
|
2735 | GLI1, GLI | GLI family zinc finger 1 |
C00001783
|
2838 | GPR15, BOB | G protein-coupled receptor 15 |
C00001783
|
2876 | GPX1, GPXD, GSHPX1 | glutathione peroxidase 1 (EC:1.11.1.9) |
C00001783
|
2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00001783
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00001783
|
2954 | GSTZ1, GSTZ1-1, MAAI, MAI | glutathione S-transferase zeta 1 (EC:2.5.1.18 5.2.1.2) |
C00001783
|
2965 | GTF2H1, BTF2, P62, TFB1, TFIIH | general transcription factor IIH, polypeptide 1, 62kDa |
C00001783
|
3044 | HBBP1 | hemoglobin, beta pseudogene 1 |
C00001783
|
113510 | HELQ, HEL308 | helicase, POLQ-like (EC:3.6.4.12) |
C00001783
|
9709 | HERPUD1, HERP, Mif1, SUP | homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
C00001783
|
3161 | HMMR, CD168, IHABP, RHAMM | hyaluronan-mediated motility receptor (RHAMM) |
C00001783
|
3265 | HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1 | Harvey rat sarcoma viral oncogene homolog |
C00001783
|
3316 | HSPB2, HSP27, Hs.78846, LOH11CR1K, MKBP | heat shock 27kDa protein 2 |
C00001783
|
3399 | ID3, HEIR-1, bHLHb25 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein |
C00001783
|
10561 | IFI44, MTAP44, TLDC5, p44 | interferon-induced protein 44 |
C00001783
|
3439 | IFNA1, IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@ | interferon, alpha 1 |
C00001783
|
3479 | IGF1, IGF-I, IGF1A, IGFI | insulin-like growth factor 1 (somatomedin C) |
C00001783
|
10643 | IGF2BP3, CT98, IMP-3, IMP3, KOC1, VICKZ3 | insulin-like growth factor 2 mRNA binding protein 3 |
C00001783
|
3500 |
C00001783
|
||
3508 | IGHMBP2, CATF1, HCSA, HMN6, SMARD1, SMUBP2, ZFAND7 | immunoglobulin mu binding protein 2 (EC:3.6.4.13 3.6.4.12) |
C00001783
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00001783
|
9118 | INA, NEF5, NF-66, TXBP-1 | internexin neuronal intermediate filament protein, alpha |
C00001783
|
9452 | ITM2A, BRICD2A, E25A | integral membrane protein 2A |
C00001783
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00001783
|
3741 | KCNA5, ATFB7, HCK1, HK2, HPCN1, KV1.5, PCN1 | potassium voltage-gated channel, shaker-related subfamily, member 5 |
C00001783
|
9757 | KMT2B, HRX2, MLL1B, MLL2, MLL4, TRX2, WBP7 | lysine (K)-specific methyltransferase 2B (EC:2.1.1.43) |
C00001783
|
3904 | LAIR2, CD306 | leukocyte-associated immunoglobulin-like receptor 2 |
C00001783
|
10859 | LILRB1, CD85J, ILT-2, ILT2, LIR-1, LIR1, MIR-7, MIR7 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
C00001783
|
11006 | LILRB4, CD85K, ILT-3, ILT3, LIR-5, LIR5 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 |
C00001783
|
4041 | LRP5, BMND1, EVR1, EVR4, HBM, LR3, LRP7, OPPG, OPS, OPTA1, VBCH2 | low density lipoprotein receptor-related protein 5 |
C00001783
|
4049 | LTA, LT, TNFB, TNFSF1 | lymphotoxin alpha |
C00001783
|
4101 | MAGEA2, CT1.2, MAGE2, MAGEA2A | melanoma antigen family A, 2 |
C00001783
|
266740 | MAGEA2B, MAGE2, MAGEA2 | melanoma antigen family A, 2B |
C00001783
|
23005 | MAPKBP1, JNKBP-1 | mitogen-activated protein kinase binding protein 1 |
C00001783
|
22919 | MAPRE1, EB1 | microtubule-associated protein, RP/EB family, member 1 |
C00001783
|
22924 | MAPRE3, EB3, EBF3, EBF3-S, RP3 | microtubule-associated protein, RP/EB family, member 3 |
C00001783
|
4153 | MBL2, COLEC1, HSMBPC, MBL, MBL2D, MBP, MBP-C, MBP1, MBPD | mannose-binding lectin (protein C) 2, soluble |
C00001783
|
54842 | MFSD6, MMR2, hMMR2 | major facilitator superfamily domain containing 6 |
C00001783
|
4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) |
C00001783
|
440823 | MIAT, C22orf35, GOMAFU, LINC00066, NCRNA00066, RNCR2 | myocardial infarction associated transcript (non-protein coding) |
C00001783
|
574456 | MIR497, MIRN497, hsa-mir-497 | microRNA 497 |
C00001783
|
4288 | MKI67, KIA, MIB-1 | marker of proliferation Ki-67 |
C00001783
|
4548 | MTR, HMAG, MS, cblG | 5-methyltetrahydrofolate-homocysteine methyltransferase (EC:2.1.1.13) |
C00001783
|
4595 | MUTYH, CYP2C, MYH | mutY homolog (EC:3.2.2.-) |
C00001783
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00001783
|
4613 | MYCN, MODED, MYCNOT, N-myc, NMYC, ODED, bHLHe37 | v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog |
C00001783
|
53904 | MYO3A, DFNB30 | myosin IIIA (EC:2.7.11.1) |
C00001783
|
9 | NAT1, AAC1, MNAT, NAT-1, NATI | N-acetyltransferase 1 (arylamine N-acetyltransferase) (EC:2.3.1.5) |
C00001783
|
4773 | NFATC2, NFAT1, NFATP | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
C00001783
|
10577 | NPC2, EDDM1, HE1 | Niemann-Pick disease, type C2 |
C00001783
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00001783
|
8829 | NRP1, BDCA4, CD304, NP1, NRP, VEGF165R | neuropilin 1 |
C00001783
|
114880 | OSBPL6, ORP6 | oxysterol binding protein-like 6 |
C00001783
|
55644 | OSGEP, GCPL1, KAE1, OSGEP1, PRSMG1 | O-sialoglycoprotein endopeptidase (EC:3.4.24.57) |
C00001783
|
8712 | PAGE1, AL5, CT16.3, GAGE-9, GAGEB1, PAGE-1 | P antigen family, member 1 (prostate associated) |
C00001783
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00001783
|
23178 | PASK, PASKIN, STK37 | PAS domain containing serine/threonine kinase (EC:2.7.11.1) |
C00001783
|
301164 |
C00001783
|
||
25894 | PLEKHG4, ARHGEF44, PRTPHN1, SCA4 | pleckstrin homology domain containing, family G (with RhoGef domain) member 4 |
C00001783
|
84898 | PLXDC2, TEM7R | plexin domain containing 2 |
C00001783
|
5376 | PMP22, CMT1A, CMT1E, DSS, GAS-3, HMSNIA, HNPP, Sp110 | peripheral myelin protein 22 |
C00001783
|
5423 | POLB | polymerase (DNA directed), beta (EC:2.7.7.7) |
C00001783
|
5428 | POLG, MDP1, MIRAS, MTDPS4A, MTDPS4B, PEO, POLG1, POLGA, SANDO, SCAE | polymerase (DNA directed), gamma (EC:2.7.7.7) |
C00001783
|
5445 | PON2 | paraoxonase 2 (EC:3.1.1.2 3.1.1.81) |
C00001783
|
5467 | PPARD, FAAR, NR1C2, NUC1, NUCI, NUCII, PPARB | peroxisome proliferator-activated receptor delta |
C00001783
|
84152 | PPP1R1B, DARPP-32, DARPP32 | protein phosphatase 1, regulatory (inhibitor) subunit 1B (EC:3.1.3.16) |
C00001783
|
9055 | PRC1, ASE1 | protein regulator of cytokinesis 1 |
C00001783
|
5621 | PRNP, ASCR, AltPrP, CD230, CJD, GSS, KURU, PRIP, PrP, PrP27-30, PrP33-35C, PrPc, p27-30 | prion protein |
C00001783
|
57716 | PRX, CMT4F | periaxin |
C00001783
|
5695 | PSMB7, Z | proteasome (prosome, macropain) subunit, beta type, 7 (EC:3.4.25.1) |
C00001783
|
5740 | PTGIS, CYP8, CYP8A1, PGIS, PTGI | prostaglandin I2 (prostacyclin) synthase (EC:5.3.99.4) |
C00001783
|
5742 | PTGS1, COX1, COX3, PCOX1, PES-1, PGG/HS, PGHS-1, PGHS1, PHS1, PTGHS | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00001783
|
2185 | PTK2B, CADTK, CAKB, FADK2, FAK2, PKB, PTK, PYK2, RAFTK | protein tyrosine kinase 2 beta (EC:2.7.10.2) |
C00001783
|
5783 | PTPN13, FAP-1, PNP1, PTP-BAS, PTP-BL, PTP1E, PTPL1, PTPLE, hPTP1E | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) (EC:3.1.3.48) |
C00001783
|
54870 | QRICH1 | glutamine-rich 1 |
C00001783
|
84991 | RBM17, SPF45 | RNA binding motif protein 17 |
C00001783
|
159162 | RBMY2FP | RNA binding motif protein, Y-linked, family 2, member F pseudogene |
C00001783
|
6001 | RGS10 | regulator of G-protein signaling 10 |
C00001783
|
26575 | RGS17, RGS-17, RGSZ2, hRGS17 | regulator of G-protein signaling 17 |
C00001783
|
6095 | RORA, NR1F1, ROR1, ROR2, ROR3, RZR-ALPHA, RZRA | RAR-related orphan receptor A |
C00001783
|
6128 | RPL6, L6, SHUJUN-2, TAXREB107, TXREB1 | ribosomal protein L6 |
C00001783
|
6240 | RRM1, R1, RIR1, RR1 | ribonucleotide reductase M1 (EC:1.17.4.1) |
C00001783
|
864 | RUNX3, AML2, CBFA3, PEBP2aC | runt-related transcription factor 3 |
C00001783
|
949 | SCARB1, CD36L1, CLA-1, CLA1, HDLQTL6, SR-BI, SRB1 | scavenger receptor class B, member 1 |
C00001783
|
6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00001783
|
5055 | SERPINB2, HsT1201, PAI, PAI-2, PAI2, PLANH2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
C00001783
|
5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00001783
|
6442 | SGCA, 50-DAG, A2, ADL, DAG2, DMDA2, LGMD2D, SCARMD1, adhalin | sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) |
C00001783
|
7979 | SHFM1, DSS1, ECD, SEM1, SHFD1, SHSF1, Shfdg1 | split hand/foot malformation (ectrodactyly) type 1 |
C00001783
|
6492 | SIM1, bHLHe14 | single-minded family bHLH transcription factor 1 |
C00001783
|
6555 | SLC10A2, ASBT, IBAT, ISBT, NTCP2, PBAM | solute carrier family 10 (sodium/bile acid cotransporter), member 2 |
C00001783
|
9990 | SLC12A6, ACCPN, KCC3, KCC3A, KCC3B | solute carrier family 12 (potassium/chloride transporter), member 6 |
C00001783
|
6584 | SLC22A5, CDSP, OCTN2, OCTN2VT | solute carrier family 22 (organic cation/carnitine transporter), member 5 |
C00001783
|
9154 | SLC28A1, CNT1, HCNT1 | solute carrier family 28 (concentrative nucleoside transporter), member 1 |
C00001783
|
6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 |
C00001783
|
28232 | SLCO3A1, OATP-D, OATP3A1, OATPD, SLC21A11 | solute carrier organic anion transporter family, member 3A1 |
C00001783
|
10592 | SMC2, CAP-E, CAPE, SMC-2, SMC2L1 | structural maintenance of chromosomes 2 |
C00001783
|
6649 | SOD3, EC-SOD | superoxide dismutase 3, extracellular (EC:1.15.1.1) |
C00001783
|
6654 | SOS1, GF1, GGF1, GINGF, HGF, NS4 | son of sevenless homolog 1 (Drosophila) |
C00001783
|
54908 | SPDL1, CCDC99 | spindle apparatus coiled-coil protein 1 |
C00001783
|
6716 | SRD5A2 | steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) (EC:1.3.1.22) |
C00001783
|
6717 | SRI, CP-22, CP22, SCN, V19 | sorcin |
C00001783
|
6756 | SSX1, CT5.1, SSRC | synovial sarcoma, X breakpoint 1 |
C00001783
|
6757 | SSX2, CT5.2, CT5.2A, HD21, HOM-MEL-40, SSX | synovial sarcoma, X breakpoint 2 |
C00001783
|
6759 | SSX4, CT5.4 | synovial sarcoma, X breakpoint 4 |
C00001783
|
548313 | SSX4B, CT5.4 | synovial sarcoma, X breakpoint 4B |
C00001783
|
6772 | STAT1, CANDF7, ISGF-3, STAT91 | signal transducer and activator of transcription 1, 91kDa |
C00001783
|
6820 | SULT2B1, HSST2 | sulfotransferase family, cytosolic, 2B, member 1 (EC:2.8.2.2) |
C00001783
|
55530 | SVOP | SV2 related protein homolog (rat) |
C00001783
|
10732 | TCFL5, CHA, E2BP-1, Figlb, bHLHe82 | transcription factor-like 5 (basic helix-loop-helix) |
C00001783
|
83660 | TLN2, ILWEQ | talin 2 |
C00001783
|
50999 | TMED5, CGI-100, p28 | transmembrane emp24 protein transport domain containing 5 |
C00001783
|
26022 | TMEM98 | transmembrane protein 98 |
C00001783
|
944 | TNFSF8, CD153, CD30L, CD30LG | tumor necrosis factor (ligand) superfamily, member 8 |
C00001783
|
7167 | TPI1, TIM, TPI, TPID | triosephosphate isomerase 1 (EC:5.3.1.1) |
C00001783
|
7173 | TPO, MSA, TDH2A, TPX | thyroid peroxidase (EC:1.11.1.8) |
C00001783
|
1200 | TPP1, CLN2, LPIC, TPP-1 | tripeptidyl peptidase I (EC:3.4.14.9) |
C00001783
|
7223 | TRPC4, HTRP-4, HTRP4, TRP4 | transient receptor potential cation channel, subfamily C, member 4 |
C00001783
|
7251 | TSG101, TSG10, VPS23 | tumor susceptibility 101 |
C00001783
|
706 | TSPO, BPBS, BZRP, DBI, IBP, MBR, PBR, PBS, PKBS, PTBR, mDRC, pk18 | translocator protein (18kDa) |
C00001783
|
1890 | TYMP, ECGF, ECGF1, MEDPS1, MNGIE, MTDPS1, PDECGF, TP, hPD-ECGF | thymidine phosphorylase (EC:2.4.2.4) |
C00001783
|
7298 | TYMS, HST422, TMS, TS | thymidylate synthetase (EC:2.1.1.45) |
C00001783
|
7350 | UCP1, SLC25A7, UCP | uncoupling protein 1 (mitochondrial, proton carrier) |
C00001783
|
7364 | UGT2B7, UDPGT_2B9, UDPGT2B7, UDPGTH2, UGT2B9 | UDP glucuronosyltransferase 2 family, polypeptide B7 (EC:2.4.1.17) |
C00001783
|
440279 | UNC13C | unc-13 homolog C (C. elegans) |
C00001783
|
7380 | UPK3A, UP3A, UPIII, UPIIIA, UPK3 | uroplakin 3A |
C00001783
|
27340 | UTP20, DRIM | UTP20, small subunit (SSU) processome component, homolog (yeast) |
C00001783
|
7421 | VDR, NR1I1 | vitamin D (1,25- dihydroxyvitamin D3) receptor |
C00001783
|
7481 | WNT11, HWNT11 | wingless-type MMTV integration site family, member 11 |
C00001783
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000176
|
169270 | ZNF596 | zinc finger protein 596 (EC:2.1.1.43) |
C00001783
|
30834 | ZNRD1, HTEX-6, Rpa12, TEX6, ZR14, hZR14, tctex-6 | zinc ribbon domain containing 1 (EC:2.7.7.6) |
C00001783
|
231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00000207
|
57016 | AKR1B10, AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI | aldo-keto reductase family 1, member B10 (aldose reductase) (EC:1.1.1.2) |
C00000207
|
898 | CCNE1, CCNE | cyclin E1 |
C00000176
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00000176
|
2235 | FECH, EPP, FCE | ferrochelatase (EC:4.99.1.1) |
C00000207
|
2512 | FTL, NBIA3 | ferritin, light polypeptide |
C00000207
|
2539 | G6PD, G6PD1 | glucose-6-phosphate dehydrogenase (EC:1.1.1.49) |
C00000207
|
2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00000207
|
2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00000207
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000207
|
4097 | MAFG, hMAF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G |
C00000207
|
4199 | ME1, HUMNDME, MES | malic enzyme 1, NADP(+)-dependent, cytosolic (EC:1.1.1.40) |
C00000207
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000176
|
4502 | MT2A, MT2 | metallothionein 2A |
C00000207
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00000207
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00000207
|
5226 | PGD, 6PGD | phosphogluconate dehydrogenase (EC:1.1.1.44) |
C00000207
|
22949 | PTGR1, LTB4DH, PGR1, ZADH3 | prostaglandin reductase 1 (EC:1.3.1.48 1.3.1.74) |
C00000207
|
6566 | SLC16A1, HHF7, MCT, MCT1 | solute carrier family 16 (monocarboxylate transporter), member 1 |
C00000207
|
140809 | SRXN1, C20orf139, Npn3, SRX, SRX1 | sulfiredoxin 1 (EC:1.8.98.2) |
C00000207
|
637 | BID, FP497 | BH3 interacting domain death agonist |
C00000176
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00000207
|
1646 | AKR1C2, AKR1C-pseudo, BABP, DD, DD2, DDH2, HAKRD, HBAB, MCDR2, SRXY8 | aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) |
C00000206
|
3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00000206
|
23764 | MAFF, U-MAF, hMafF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
C00000206
|
55867 | SLC22A11, OAT4, hOAT4 | solute carrier family 22 (organic anion/urate transporter), member 11 |
C00000206
|
9356 | SLC22A6, HOAT1, OAT1, PAHT, ROAT1 | solute carrier family 22 (organic anion transporter), member 6 |
C00000206
|
10864 | SLC22A7, NLT, OAT2 | solute carrier family 22 (organic anion transporter), member 7 |
C00000206
|
114571 | SLC22A9, HOAT4, OAT4, OAT7, UST3H, ust3 | solute carrier family 22 (organic anion transporter), member 9 |
C00000206
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00000206
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00000206
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00000206
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00000206
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#104300 | Alzheimer disease; ad |
P05067
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#613393 | Birbeck granule deficiency |
Q9UJ71
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605714 | Cerebral amyloid angiopathy, app-related |
P05067
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#614039 | Cortical dysplasia, complex, with other brain malformations 1; cdcbm1 |
Q13509
|
#162800 | Cyclic neutropenia |
P08246
|
#614371 | Dengue virus, susceptibility to |
Q9NNX6
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#128101 | Dystonia 4, torsion, autosomal dominant; dyt4 |
P04350
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#612219 | Ewing sarcoma; es |
P11308
|
#600638 | Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement; cfeom3a |
Q13509
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 |
#232600 | Glycogen storage disease v |
P11217
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#610424 | Hepatitis b virus, susceptibility to |
P11226
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#146300 | Hypophosphatasia, adult |
P05186
|
#241510 | Hypophosphatasia, childhood |
P05186
|
#241500 | Hypophosphatasia, infantile |
P05186
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#613496 | Immunodeficiency, common variable, 6; cvid6 |
P60033
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#612438 | Leukodystrophy, hypomyelinating, 6; hld6 |
P04350
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#611603 | Lissencephaly 3; lis3 |
Q71U36
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#613112 | Macrothrombocytopenia, autosomal dominant, tubb1-related |
Q9H4B7
|
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#614372 | Mannose-binding protein deficiency |
P11226
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#253220 | Mucopolysaccharidosis, type vii; mps7 |
P08236
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
Q9NNX6
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#610031 | Polymicrogyria, symmetric or asymmetric; pmgysa |
Q9BVA1
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) P08253 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00081 | Hashimoto's thyroiditis |
P01215
(marker)
|
H00082 | Graves' disease |
P01215
(marker)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P01215
(marker)
P16473 (related) |
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P17931 (marker) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00056 | Alzheimer's disease (AD) |
P05067
(related)
|
H01185 | Cerebral amyloid angiopathy (CAA) |
P05067
(related)
|
H00213 | Hypophosphatasia |
P05186
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00132 | Mucopolysaccharidosis type VII (MPS7) |
P08236
(related)
|
H00421 | Mucopolysaccharidosis (MPS) |
P08236
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P11217
(related)
|
H00105 | Mannose-binding lectin pathway component defects |
P11226
(related)
|
H00342 | Tuberculosis |
P11226
(related)
|
H00024 | Prostate cancer |
P11308
(related)
|
H00035 | Ewing's sarcoma |
P11308
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00088 | Common variable immunodeficiency (CVID) |
P60033
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00838 | Congenital fibrosis of the extraocular muscles (CFEOM) |
Q13509
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00268 | Lissencephaly (LIS) |
Q71U36
(related)
|
H00208 | Hyperbilirubinemia |
Q92887
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D001943 | Breast Neoplasms |
C00000176
C00001783 |
D011471 | Prostatic Neoplasms |
C00000176
C00001783 |
D014012 | Tinnitus |
C00001783
C00000206 |
D012640 | Seizures |
C00001783
C00000206 |
D006685 | Hoarseness |
C00001783
C00000206 |
D034381 | Hearing Loss |
C00001783
C00000206 |
D003128 | COMA |
C00001783
C00000206 |
D015173 | Supratentorial Neoplasms |
C00001783
|
D000471 | Alkalosis |
C00001783
|
D000505 | Alopecia |
C00001783
|
D000707 | Anaphylaxis |
C00001783
|
D000740 | Anemia |
C00001783
|
D000787 | Angina Pectoris |
C00001783
|
D000855 | Anorexia |
C00001783
|
D001037 | Aphasia |
C00001783
|
D001044 | Aphonia |
C00001783
|
D001146 | Arrhythmia, Sinus |
C00001783
|
D001201 | Ascites |
C00001783
|
D001254 | Astrocytoma |
C00001783
|
D001259 | Ataxia |
C00001783
|
D001264 | Athetosis |
C00001783
|
D001342 | Autonomic Nervous System Diseases |
C00001783
|
D053099 | Azotemia |
C00001783
|
D001763 | Blepharoptosis |
C00001783
|
D001766 | Blindness |
C00001783
|
D019575 | Blindness, Cortical |
C00001783
|
C536572 | Bone Marrow failure syndromes |
C00001783
|
D019046 | Bone Marrow Neoplasms |
C00001783
|
D001927 | Brain Diseases |
C00001783
|
D001930 | Brain Injuries |
C00001783
|
D001932 | Brain Neoplasms |
C00001783
|
D002051 | Burkitt Lymphoma |
C00001783
|
D002277 | Carcinoma |
C00001783
|
D002283 | Carcinoma, Bronchogenic |
C00001783
|
D018236 | Carcinoma, Embryonal |
C00001783
|
D002292 | Carcinoma, Renal Cell |
C00001783
|
D018288 | Carcinoma, Small Cell |
C00001783
|
D002294 | Carcinoma, Squamous Cell |
C00001783
|
C535575 | Carcinoma, squamous cell of head and neck |
C00001783
|
D002295 | Carcinoma, Transitional Cell |
C00001783
|
D009202 | Cardiomyopathies |
C00001783
|
D002493 | Central Nervous System Diseases |
C00001783
|
D016543 | Central Nervous System Neoplasms |
C00001783
|
D002526 | Cerebellar Diseases |
C00001783
|
D002543 | Cerebral Hemorrhage |
C00001783
|
D002607 | Charcot-Marie-Tooth Disease |
C00001783
|
D002817 | Chordoma |
C00001783
|
D002819 | Chorea |
C00001783
|
D015179 | Colorectal Neoplasms |
C00001783
|
D000230 | Adenocarcinoma |
C00001783
|
D003221 | Confusion |
C00001783
|
D000013 | Congenital Abnormalities |
C00001783
|
D003248 | Constipation |
C00001783
|
D003316 | Corneal Diseases |
C00001783
|
D003328 | Coronary Thrombosis |
C00001783
|
D003389 | Cranial Nerve Diseases |
C00001783
|
D003556 | Cystitis |
C00001783
|
D003680 | Deglutition Disorders |
C00001783
|
D003711 | Demyelinating Diseases |
C00001783
|
D058405 | Desmoplastic Small Round Cell Tumor |
C00001783
|
D003967 | Diarrhea |
C00001783
|
D004172 | Diplopia |
C00001783
|
D004195 | Disease Models, Animal |
C00001783
|
D006970 | Disorders of Excessive Somnolence |
C00001783
|
D056486 | Drug-Induced Liver Injury |
C00001783
|
D062787 | Drug Overdose |
C00001783
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00001783
|
D004401 | Dysarthria |
C00001783
|
D055154 | Dysphonia |
C00001783
|
D004487 | Edema |
C00001783
|
D004802 | Eosinophilia |
C00001783
|
D004806 | Ependymoma |
C00001783
|
D004830 | Epilepsy, Tonic-Clonic |
C00001783
|
D004890 | Erythema |
C00001783
|
D004938 | Esophageal Neoplasms |
C00001783
|
D005076 | Exanthema |
C00001783
|
D005155 | Facial Nerve Diseases |
C00001783
|
D005157 | Facial Pain |
C00001783
|
D005158 | Facial Paralysis |
C00001783
|
D005221 | Fatigue |
C00001783
|
D005242 | Fecal Incontinence |
C00001783
|
D005334 | Fever |
C00001783
|
D005530 | Foot Deformities |
C00001783
|
D005683 | Gagging |
C00001783
|
D020234 | Gait Ataxia |
C00001783
|
D020233 | Gait Disorders, Neurologic |
C00001783
|
D005767 | Gastrointestinal Diseases |
C00001783
|
D018589 | Gastroparesis |
C00001783
|
D005910 | Glioma |
C00001783
|
D005911 | Gliosis |
C00001783
|
D020435 | Glossopharyngeal Nerve Diseases |
C00001783
|
D006212 | Hallucinations |
C00001783
|
D006311 | Hearing Disorders |
C00001783
|
D058186 | Acute Kidney Injury |
C00001783
|
D006312 | Hearing Loss, Bilateral |
C00001783
|
D006319 | Hearing Loss, Sensorineural |
C00001783
|
D003639 | Hearing Loss, Sudden |
C00001783
|
D006331 | Heart Diseases |
C00001783
|
D018325 | Hemangioblastoma |
C00001783
|
D006402 | Hematologic Diseases |
C00001783
|
D006408 | Hematoma, Subdural |
C00001783
|
D006417 | Hematuria |
C00001783
|
D006429 | Hemiplegia |
C00001783
|
D006461 | Hemolysis |
C00001783
|
D006463 | Hemolytic-Uremic Syndrome |
C00001783
|
D006504 | Hepatic Veno-Occlusive Disease |
C00001783
|
D006529 | Hepatomegaly |
C00001783
|
D020434 | Abducens Nerve Diseases |
C00001783
|
D006689 | Hodgkin Disease |
C00001783
|
D006930 | Hyperalgesia |
C00001783
|
D006932 | Hyperbilirubinemia |
C00001783
|
D006947 | Hyperkalemia |
C00001783
|
D006973 | Hypertension |
C00001783
|
D006987 | Hypesthesia |
C00001783
|
D006996 | Hypocalcemia |
C00001783
|
D020437 | Hypoglossal Nerve Diseases |
C00001783
|
D007008 | Hypokalemia |
C00001783
|
D007010 | Hyponatremia |
C00001783
|
D007022 | Hypotension |
C00001783
|
D007024 | Hypotension, Orthostatic |
C00001783
|
D007049 | Iatrogenic Disease |
C00001783
|
D045823 | Ileus |
C00001783
|
D007177 | Inappropriate ADH Syndrome |
C00001783
|
D007418 | Intestinal Pseudo-Obstruction |
C00001783
|
D020767 | Intracranial Thrombosis |
C00001783
|
D007674 | Kidney Diseases |
C00001783
|
D007680 | Kidney Neoplasms |
C00001783
|
D007890 | Leiomyosarcoma |
C00001783
|
D053609 | Lethargy |
C00001783
|
D007938 | Leukemia |
C00001783
|
D007945 | Leukemia, Lymphoid |
C00001783
|
D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
C00001783
|
D007951 | Leukemia, Myeloid |
C00001783
|
D015470 | Leukemia, Myeloid, Acute |
C00001783
|
D015477 | Leukemia, Myelomonocytic, Chronic |
C00001783
|
D007952 | Leukemia, Plasma Cell |
C00001783
|
D015473 | Leukemia, Promyelocytic, Acute |
C00001783
|
D015458 | Leukemia, T-Cell |
C00001783
|
D056784 | Leukoencephalopathies |
C00001783
|
D007970 | Leukopenia |
C00001783
|
D008107 | Liver Diseases |
C00001783
|
D008175 | Lung Neoplasms |
C00001783
|
D008180 | Lupus Erythematosus, Systemic |
C00001783
|
D008223 | Lymphoma |
C00001783
|
D016483 | Lymphoma, AIDS-Related |
C00001783
|
D016393 | Lymphoma, B-Cell |
C00001783
|
D016403 | Lymphoma, Large B-Cell, Diffuse |
C00001783
|
D008228 | Lymphoma, Non-Hodgkin |
C00001783
|
D016399 | Lymphoma, T-Cell |
C00001783
|
D008527 | Medulloblastoma |
C00001783
|
D018328 | Melanoma, Amelanotic |
C00001783
|
D008580 | Meningism |
C00001783
|
D008590 | Meningoencephalitis |
C00001783
|
D020422 | Mononeuropathies |
C00001783
|
D016472 | Motor Neuron Disease |
C00001783
|
D019957 | Motor Skills Disorders |
C00001783
|
D009062 | Mouth Neoplasms |
C00001783
|
D009069 | Movement Disorders |
C00001783
|
D009101 | Multiple Myeloma |
C00001783
|
D009120 | Muscle Cramp |
C00001783
|
D009123 | Muscle Hypotonia |
C00001783
|
D018908 | Muscle Weakness |
C00001783
|
D009133 | Muscular Atrophy |
C00001783
|
D009182 | Mycosis Fungoides |
C00001783
|
D009203 | Myocardial Infarction |
C00001783
|
D017202 | Myocardial Ischemia |
C00001783
|
D020967 | Myotonic Disorders |
C00001783
|
D009325 | Nausea |
C00001783
|
D009336 | Necrosis |
C00001783
|
D009362 | Neoplasm Metastasis |
C00001783
|
D018213 | Neoplasms, Bone Tissue |
C00001783
|
D018302 | Neoplasms, Neuroepithelial |
C00001783
|
D009404 | Nephrotic Syndrome |
C00001783
|
D009410 | Nerve Degeneration |
C00001783
|
D009422 | Nervous System Diseases |
C00001783
|
D009437 | Neuralgia |
C00001783
|
D019150 | Neuroaxonal Dystrophies |
C00001783
|
D019954 | Neurobehavioral Manifestations |
C00001783
|
D009447 | Neuroblastoma |
C00001783
|
D017599 | Neuroectodermal Tumors |
C00001783
|
D018241 | Neuroectodermal Tumors, Primitive, Peripheral |
C00001783
|
D009468 | Neuromuscular Diseases |
C00001783
|
D020511 | Neuromuscular Junction Diseases |
C00001783
|
D020258 | Neurotoxicity Syndromes |
C00001783
|
D009503 | Neutropenia |
C00001783
|
C537844 | Nonseminomatous germ cell tumor |
C00001783
|
D015840 | Oculomotor Nerve Diseases |
C00001783
|
D000857 | Olfaction Disorders |
C00001783
|
D009837 | Oligodendroglioma |
C00001783
|
D009886 | Ophthalmoplegia |
C00001783
|
D009896 | Optic Atrophy |
C00001783
|
D009901 | Optic Nerve Diseases |
C00001783
|
D020339 | Optic Nerve Glioma |
C00001783
|
D019226 | Oral Ulcer |
C00001783
|
D012516 | Osteosarcoma |
C00001783
|
D010051 | Ovarian Neoplasms |
C00001783
|
D010146 | Pain |
C00001783
|
D010190 | Pancreatic Neoplasms |
C00001783
|
D010243 | Paralysis |
C00001783
|
D010264 | Paraplegia |
C00001783
|
D010291 | Paresis |
C00001783
|
D010292 | Paresthesia |
C00001783
|
D010302 | Parkinson Disease, Secondary |
C00001783
|
D010523 | Peripheral Nervous System Diseases |
C00001783
|
D010842 | Pica |
C00001783
|
D011115 | Polyneuropathies |
C00001783
|
D011129 | Polyradiculoneuropathy |
C00001783
|
D015452 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma |
C00001783
|
D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
C00001783
|
D054218 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma |
C00001783
|
D011552 | Pseudomonas Infections |
C00001783
|
D016553 | Purpura, Thrombocytopenic, Idiopathic |
C00001783
|
D011782 | Quadriplegia |
C00001783
|
D011928 | Raynaud Disease |
C00001783
|
D012008 | Recurrence |
C00001783
|
D012021 | Reflex, Abnormal |
C00001783
|
D051437 | Renal Insufficiency |
C00001783
|
D012131 | Respiratory Insufficiency |
C00001783
|
D012133 | Respiratory Paralysis |
C00001783
|
D012135 | Respiratory Sounds |
C00001783
|
D012162 | Retinal Degeneration |
C00001783
|
D012183 | Retrograde Degeneration |
C00001783
|
D012208 | Rhabdomyosarcoma |
C00001783
|
D012512 | Sarcoma, Ewing |
C00001783
|
D012514 | Sarcoma, Kaposi |
C00001783
|
D013584 | Sarcoma, Synovial |
C00001783
|
D020426 | Sciatic Neuropathy |
C00001783
|
D015746 | Abdominal Pain |
C00001783
|
D012678 | Sensation Disorders |
C00001783
|
D018805 | Sepsis |
C00001783
|
D012871 | Skin Diseases |
C00001783
|
D012878 | Skin Neoplasms |
C00001783
|
D055752 | Small Cell Lung Carcinoma |
C00001783
|
D020886 | Somatosensory Disorders |
C00001783
|
D013120 | Spinal Cord Neoplasms |
C00001783
|
D013125 | Spinal Neoplasms |
C00001783
|
D013163 | Splenomegaly |
C00001783
|
D013280 | Stomatitis |
C00001783
|
D013479 | Superior Vena Cava Syndrome |
C00001783
|
D000380 | Agranulocytosis |
C00001783
|
D013724 | Teratoma |
C00001783
|
D013736 | Testicular Neoplasms |
C00001783
|
D013921 | Thrombocytopenia |
C00001783
|
D013923 | Thromboembolism |
C00001783
|
D013927 | Thrombosis |
C00001783
|
D013964 | Thyroid Neoplasms |
C00001783
|
D008569 | Memory Disorders |
C00003088
|
D014202 | Tremor |
C00001783
|
D020433 | Trigeminal Nerve Diseases |
C00001783
|
D014511 | Uremia |
C00001783
|
D001745 | Urinary Bladder Diseases |
C00001783
|
D001749 | Urinary Bladder Neoplasms |
C00001783
|
D001750 | Urinary Bladder, Neurogenic |
C00001783
|
D014549 | Urinary Incontinence |
C00001783
|
D016055 | Urinary Retention |
C00001783
|
D014555 | Urination Disorders |
C00001783
|
D002583 | Uterine Cervical Neoplasms |
C00001783
|
D020421 | Vagus Nerve Diseases |
C00001783
|
D020301 | Vasospasm, Intracranial |
C00001783
|
D014786 | Vision Disorders |
C00001783
|
D014826 | Vocal Cord Paralysis |
C00001783
|
D014832 | Voice Disorders |
C00001783
|
D014839 | Vomiting |
C00001783
|
D014855 | Wallerian Degeneration |
C00001783
|
D014883 | Water-Electrolyte Imbalance |
C00001783
|
D009396 | Wilms Tumor |
C00001783
|
D000647 | Amnesia |
C00000091
|
D003877 | Dermatitis, Contact |
C00000207
|
D001249 | Asthma |
C00000206
|
D004342 | Drug Hypersensitivity |
C00000206
|
D007819 | Laryngeal Edema |
C00000206
|
D009668 | Nose Diseases |
C00000206
|
D049188 | Prenatal Injuries |
C00000206
|
D014581 | Urticaria |
C00000206
|
D014860 | Warts |
C00000206
|